Christian Behrenbruch
Founder at TELIX PHARMACEUTICALS LIMITED
Net worth: 222 M $ as of 30/04/2024
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Melanie Farris | F | - |
Advanced Nuclear Medicine Ingredients SA
 Advanced Nuclear Medicine Ingredients SA Wholesale DistributorsDistribution Services Advanced Nuclear Medicine Ingredients SA engages in the distribution of pharmaceutical ingredients. Its products and services include toward cold kits for PET, custom peptide synthesis, new theranostic cold kits and theranostic development. The company was founded by Bruno Colard, Severine Plunus, Laurent Bodson, Monique Body, Amadeo Falcone, Sabine Lurson, Gael Minon, Michel Falcone, Vanessa Charlier, Chantal Riviere, Jean Francois Kaisin, Samuel Voccia, and Ludovic Wouters on March 27, 2015 and is headquartered in Liege, Belgium. | 6 years |
| Andreas Kluge | M | - | 9 years | |
| Warwick Tong | M | - | 6 years | |
| David Cade | M | - | 5 years | |
| James Stonecypher | M | - | - | |
| Kyahn Williamson | F | - | 3 years | |
| Jyoti Arora | M | - | - | |
| Douglas Cubbin | M | - |
Advanced Nuclear Medicine Ingredients SA
Advanced Nuclear Medicine Ingredients SA Wholesale DistributorsDistribution Services Advanced Nuclear Medicine Ingredients SA engages in the distribution of pharmaceutical ingredients. Its products and services include toward cold kits for PET, custom peptide synthesis, new theranostic cold kits and theranostic development. The company was founded by Bruno Colard, Severine Plunus, Laurent Bodson, Monique Body, Amadeo Falcone, Sabine Lurson, Gael Minon, Michel Falcone, Vanessa Charlier, Chantal Riviere, Jean Francois Kaisin, Samuel Voccia, and Ludovic Wouters on March 27, 2015 and is headquartered in Liege, Belgium. | 6 years |
| Harry McCann | M | 83 | 7 years | |
| Jann Skinner | F | 66 | 6 years | |
| Richard Valeix | M | - |
Advanced Nuclear Medicine Ingredients SA
Advanced Nuclear Medicine Ingredients SA Wholesale DistributorsDistribution Services Advanced Nuclear Medicine Ingredients SA engages in the distribution of pharmaceutical ingredients. Its products and services include toward cold kits for PET, custom peptide synthesis, new theranostic cold kits and theranostic development. The company was founded by Bruno Colard, Severine Plunus, Laurent Bodson, Monique Body, Amadeo Falcone, Sabine Lurson, Gael Minon, Michel Falcone, Vanessa Charlier, Chantal Riviere, Jean Francois Kaisin, Samuel Voccia, and Ludovic Wouters on March 27, 2015 and is headquartered in Liege, Belgium. | 3 years |
| David Brookes | M | 63 | 5 years | |
| Darren Smith | M | 58 | 2 years | |
| Tracey Brown | M | 61 | 4 years | |
| Tiffany Olson | F | 64 | 2 years | |
| Mark Nelson | M | - | 7 years | |
| Lena Moran-Adams | F | - | - | |
| Raphaël Ortiz | M | - | 2 years | |
| Michael Didocha | M | - | 3 years | |
| K. Judson | M | 62 |
ImaginAb, Inc.
 ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | 12 years |
| Michael Wheatcroft | M | - | - | |
| Craig Ulrick | M | - | - | |
| Genevieve Ryan | F | - | 2 years | |
| Peter Coleman | M | 64 |
Monash Engineering Foundation
| - |
| Meredith Crowe | F | - | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Saskia Jo | F | - | - | |
| Cherrell Hirst | M | 78 | 11 years | |
| Hedie Meka | M | - | - | |
| Jonathan Barlow | M | - | 5 years | |
| Nigel Johnson | M | - | 14 years | |
| Abbie Celniker | M | 65 |
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | - |
| Mel Bridges | M | 73 | 6 years | |
| Elizabeth M. Hopkins | F | 60 | 5 years | |
| John Nicholas Lambert | M | 73 | 3 years | |
| Andrew Sneddon | M | 67 | 5 years | |
| Richard Golin | M | 71 |
CTI Molecular Imaging, Inc.
 CTI Molecular Imaging, Inc. Medical SpecialtiesHealth Technology CTI Molecular Imaging, Inc. makes positron emission tomography (PET) scanners that provide early detection of cancer, cardiac disease and neurological disorders. The company's PETNet unit makes radiopharmaceuticals and distributes them through more than 40 'radiopharmacies' across the US as well as in the UK and South Korea. CTI also makes detector materials used in the PET scanners. CTI markets its products to hospitals, universities and imaging and cancer treatment centers. The company is headquartered in Knoxville, TN | 2 years |
| David Eisler | M | 45 |
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | 1 years |
| David Gill | M | 69 |
CTI Molecular Imaging, Inc.
CTI Molecular Imaging, Inc. Medical SpecialtiesHealth Technology CTI Molecular Imaging, Inc. makes positron emission tomography (PET) scanners that provide early detection of cancer, cardiac disease and neurological disorders. The company's PETNet unit makes radiopharmaceuticals and distributes them through more than 40 'radiopharmacies' across the US as well as in the UK and South Korea. CTI also makes detector materials used in the PET scanners. CTI markets its products to hospitals, universities and imaging and cancer treatment centers. The company is headquartered in Knoxville, TN | 3 years |
| Rosalind Wilson | M | - | 2 years | |
| Oliver Buck | M | - | 5 years | |
| Heather Raines | F | 58 |
CTI Molecular Imaging, Inc.
CTI Molecular Imaging, Inc. Medical SpecialtiesHealth Technology CTI Molecular Imaging, Inc. makes positron emission tomography (PET) scanners that provide early detection of cancer, cardiac disease and neurological disorders. The company's PETNet unit makes radiopharmaceuticals and distributes them through more than 40 'radiopharmacies' across the US as well as in the UK and South Korea. CTI also makes detector materials used in the PET scanners. CTI markets its products to hospitals, universities and imaging and cancer treatment centers. The company is headquartered in Knoxville, TN | 6 years |
| Helen Hovenga | F | - | 1 years | |
| Gabriel Liberatore | M | - | 3 years | |
| Colin Hayward | M | - | 4 years | |
| Timothy Richard Hughes | M | - | 5 years | |
| Robert P. Ryan | M | - | 2 years | |
| Thomas Hook | M | 61 |
CTI Molecular Imaging, Inc.
CTI Molecular Imaging, Inc. Medical SpecialtiesHealth Technology CTI Molecular Imaging, Inc. makes positron emission tomography (PET) scanners that provide early detection of cancer, cardiac disease and neurological disorders. The company's PETNet unit makes radiopharmaceuticals and distributes them through more than 40 'radiopharmacies' across the US as well as in the UK and South Korea. CTI also makes detector materials used in the PET scanners. CTI markets its products to hospitals, universities and imaging and cancer treatment centers. The company is headquartered in Knoxville, TN | 2 years |
| John Michailidis | M | - | 4 years | |
| Timothy Oldham | M | - |
Cell Therapies Pty Ltd.
| 3 years |
| Roger Crystal | M | 47 |
ImaginAb, Inc.
ImaginAb, Inc. Medical SpecialtiesHealth Technology ImaginAb, Inc. develops engineered antibody fragments for diagnostic imaging and novel therapeutic applications. It products offer actionable data to facilitate diagnosis of disease, inform better treatment decisions, and monitor response to therapy. The firm also offers a range of pre-clinical (animal imaging) reagents for use with microPET, microSPECT, and optical imaging systems. The company was founded by Christian P. Behrenbruch, Tove Olafsen, Anna M. Wu, and Robert E. Reiter in 2007 and is headquartered in Inglewood, CA. | 2 years |
| Christopher Collins | M | 74 | 12 years | |
| Michael Quinn Anthony | M | 76 | 5 years | |
| Joseph Sardano | M | 71 |
CTI Molecular Imaging, Inc.
CTI Molecular Imaging, Inc. Medical SpecialtiesHealth Technology CTI Molecular Imaging, Inc. makes positron emission tomography (PET) scanners that provide early detection of cancer, cardiac disease and neurological disorders. The company's PETNet unit makes radiopharmaceuticals and distributes them through more than 40 'radiopharmacies' across the US as well as in the UK and South Korea. CTI also makes detector materials used in the PET scanners. CTI markets its products to hospitals, universities and imaging and cancer treatment centers. The company is headquartered in Knoxville, TN | 3 years |
| R. Gregory Brophy | M | 64 |
CTI Molecular Imaging, Inc.
CTI Molecular Imaging, Inc. Medical SpecialtiesHealth Technology CTI Molecular Imaging, Inc. makes positron emission tomography (PET) scanners that provide early detection of cancer, cardiac disease and neurological disorders. The company's PETNet unit makes radiopharmaceuticals and distributes them through more than 40 'radiopharmacies' across the US as well as in the UK and South Korea. CTI also makes detector materials used in the PET scanners. CTI markets its products to hospitals, universities and imaging and cancer treatment centers. The company is headquartered in Knoxville, TN | 3 years |
| Sunil Kadam | M | - | - |
Statistics
| Country | Connections | % of total |
|---|---|---|
| Australia | 45 | 81.82% |
| United States | 10 | 18.18% |
| Belgium | 3 | 5.45% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Christian Behrenbruch
- Personal Network
